Peptide Therapy Innovations for Triple Negative Breast Cancer The Cancer Advances podcast is joined by Ofer Reizes, PhD, the Laura J
Ghrelin Receptor (GHS-R1a) Selective Activation Ipamorelin acts as a highly selective agonist of the growth hormone secretagogue receptor (GHS-R1a), mimicking the natural hormone ghrelin without affecting other pituitary hormone secretion: Selective binding to GHS-R1a receptors without stimulating ACTH, cortisol, or prolactin release Rapid onset of growth hormone pulse generation (peak levels within 40-60 minutes) No significant effect on appetite stimulation unlike other ghrelin mimetics Preserved feedback regulation through endogenous growth hormone-releasing inhibitory mechanisms Research indicates that ipamorelin releases growth hormone with potency and efficacy similar to GHRP-6 (EC50 approximately 1.3 nmol/L) but with superior selectivity for growth hormone secretion
By the end, youll gain insights into treating stubborn injuries effectively
Lyophilisation, or freeze-drying, ensures that peptides are preserved by removing water and creating a stable, solid puck
A 30G bends sideways against that geometry
GH secretagogue peptides restore a more youthful GH pulse amplitude, slowing or reversing age-related lean tissue loss and supporting the body composition that resistance training alone cannot fully maintain as GH output falls
